Drug company trading boost

PET drugs company Dechra Pharmaceuticals has said overall trading in the last three months continued to be positive despite the disruption caused by the poor weather in January.

The group, which has its Dales Pharmaceuticals manufacturing plant in Skipton, develops and makes drugs and food for animals through its pharmaceuticals division and supplies drugs and services to the veterinary industry through its services arm.

Group revenue for the three months ended March 31, 2010, was 5.7 per cent ahead of last year. For the nine months ended March 31 2010, revenue increased by 6.3 per cent over the corresponding period in the prior year.

In a statement, the company said there have been a number of advancements in its products.

The group said: "We remain confident that the group will continue to make good strategic progress"